Case number 1:18-cv-01606
Anacor Pharmaceuticals, Inc. v. Lupin Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Sep 27, 2021 | 112 | Memorandum and Order (5) Docket Text: MEMORANDUM ORDER: The Report and Recommendation (D.I. [108]) is ADOPTED. FlatWing's Motion for Attorneys' Fees (D.I. [98]) is DENIED. Signed by Judge Richard G. Andrews on 9/27/2021. (nms) |
| Jul 21, 2021 | 111 | Response to Objections (13) Docket Text: RESPONSE to [109] Objections, by Anacor Pharmaceuticals, Inc..(Dellinger, Megan) Modified on 7/21/2021 (nms). |
| Jul 9, 2021 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The main pdfs for D.I. [109] and D.I. [110] have been replaced with amended versions. The captions on the filings have been corrected to add reference to the MDL case this civil action is a part of. The NEFs for the filings has been regenerated. (nms) |
| Jul 8, 2021 | N/A | Deficiency Notice (0) Docket Text: DEFICIENCY NOTICE by the Court issued to FlatWing Pharmaceuticals, LLC re [110] Sealed Declaration. This filing does not comply with Local Rule 5.2(b)(1). FlatWing Pharmaceuticals, LLC is requested to supplement the docket accordingly. (nms) |
| Jul 7, 2021 | 109 | Main Document (14) Docket Text: OBJECTION to [108] Report and Recommendations by FlatWing Pharmaceuticals, LLC. (Attachments: # (1) Certification)(Phillips, John) (Main Document 109 replaced on 7/9/2021) (nms). |
| Jul 7, 2021 | 109 | Certification (1) |
| Jul 7, 2021 | 110 | Declaration (8) Docket Text: DECLARATION of Don J. Mizerk re [109] Objection to Report and Recommendations, by FlatWing Pharmaceuticals, LLC. (Phillips, John) Modified on 7/8/2021 (nms). Modified on 7/8/2021 (nms). (Main Document 110 replaced on 7/9/2021) (nms). |
| Jun 23, 2021 | 108 | Report and Recommendations (7) Docket Text: REPORT AND RECOMMENDATION re Defendant FlatWing Pharmaceuticals, LLC's Motion for Attorney Fees pursuant to 35 U.S.C. § 285 (No. 18-1606-RGA, D.I. 98; No. 19-md-2884-RGA, D.I. 79.) Please note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing consists solely of the Objections (no longer than ten (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. Objections to R&R due by 7/7/2021. The hearing scheduled for June 24, 2021 is CANCELLED. Signed by Judge Jennifer L. Hall on 6/23/2021. Associated Cases: 1:18-cv-01606-RGA, 1:19-md-02884-RGA(ceg) |
| Apr 26, 2021 | N/A | Order Setting Hearing on Motion (0) Docket Text: ORAL ORDER Setting Hearing on Motion: A hearing on the pending Motion for Attorney Fees Pursuant to 35 U.S.C. § 285 (D.I. [98]) is scheduled for Thursday, June 24, 2021 at 3:00 PM Eastern Time via video conference before Judge Jennifer L. Hall. Each side will be allocated 10 minutes for argument. The parties shall send a joint email to Cailah_Garfinkel@ded.uscourts.gov containing the following information regarding oral argument on or before June 22, 2021: (1) a video conference link with instructions on how to join the conference; (2) a separate audio-only dial-in; and (3) a list of attendees for each party, specifying who will be presenting argument. Any video conference must be sufficient to accommodate Judge Hall, the courtroom deputy, a law clerk, and the court reporter. Any slide presentations or demonstratives that the parties wish to use during the hearing shall be emailed to Cailah_Garfinkel@ded.uscourts.gov no later than 24 hours prior to the hearing. Slide presentations or demonstratives may be presented by the parties on the video conference screen or referred to by the parties at the hearing. Once the dial-in information is received by the Court, members of the public may obtain it by contacting Chambers at Cailah_Garfinkel@ded.uscourts.gov. All participants (including any media and members of the public) are reminded that recording or broadcasting proceedings is STRICTLY PROHIBITED. All participants shall be present on the video conference no later than 10 minutes prior to the start of the hearing. The Court may choose to resolve the pending motion prior to the hearing and will, in that event, cancel the hearing. ORDERED by Judge Jennifer L. Hall on 4/26/2021. (ceg) |
| Apr 1, 2021 | N/A | Order Referring Motion (0) Docket Text: ORAL ORDER: The Motion for Attorney Fees Pursuant to 35 U.S.C. § 285 (D.I. [98]) is now REFERRED to Magistrate Judge Jennifer L. Hall. Ordered by Judge Richard G. Andrews on 4/1/2021. Motions referred to Jennifer L. Hall.(nms) |
| Dec 16, 2020 | 105 | Request for Oral Argument (1) Docket Text: REQUEST for Oral Argument by FlatWing Pharmaceuticals, LLC. (Phillips, John) Modified on 12/16/2020 (nms). |
| Dec 15, 2020 | 104 | Main Document (14) Docket Text: REPLY BRIEF re [98] MOTION for Attorney Fees Pursuant to 35 U.S.C. § 285, filed by FlatWing Pharmaceuticals, LLC. (Attachments: # (1) Exhibits S-T)(Phillips, John) Modified on 12/15/2020 (nms). |
| Dec 15, 2020 | 104 | Exhibits S-T (101) |
| Nov 23, 2020 | 102 | Answering Brief in Opposition (26) Docket Text: ANSWERING BRIEF in Opposition re [98] MOTION for Attorney Fees Pursuant to 35 U.S.C. § 285 filed by Anacor Pharmaceuticals, Inc..Reply Brief due date per Local Rules is 11/30/2020. (Dellinger, Megan) |
| Nov 23, 2020 | 103 | Main Document (6) Docket Text: DECLARATION of Anthony H. Sheh re [102] Answering Brief in Opposition, by Anacor Pharmaceuticals, Inc.. (Attachments: # (1) Exhibits 1-26)(Dellinger, Megan) Modified on 11/24/2020 (nms). |
| Nov 23, 2020 | 103 | Exhibit 1-26 (659) |
| Oct 28, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (82 in 19-md-2884-RGA; 101 in 18-cv-1606-RGA) Stipulation and Proposed Order to Extend Time (*Reset Briefing Schedule: re D.I. 79 in 19-md-2884-RGA, and D.I. 98 in 18-cv-1606-RGA)MOTION for Attorney Fees. Answering Brief due 11/23/2020, Reply Brief due 12/14/2020). Signed by Judge Richard G. Andrews on 10/28/2020. Associated Cases: 1:18-cv-01606-RGA, 1:19-md-02884-RGA(nms) |
| Oct 28, 2020 | 101 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION and Proposed Order to Extend Time - filed by Anacor Pharmaceuticals, Inc.. (Dellinger, Megan) Modified on 10/28/2020 (nms). |
| Oct 26, 2020 | 98 | Main Document (2) Docket Text: MOTION for Attorney Fees Pursuant to 35 U.S.C. § 285 - filed by FlatWing Pharmaceuticals, LLC. (Attachments: # (1) Proposed Order, # (2) 7.1.1 Statement)(Phillips, John) Modified on 10/27/2020 (nms). |
| Oct 26, 2020 | 98 | Text of Proposed Order (1) |
| Oct 26, 2020 | 98 | Rule 7.1.1 Statement (1) |
| Oct 26, 2020 | 99 | Opening Brief in Support (24) Docket Text: OPENING BRIEF in Support re [98] MOTION for Attorney Fees Pursuant to 35 U.S.C. § 285, filed by FlatWing Pharmaceuticals, LLC.Answering Brief/Response due date per Local Rules is 11/9/2020. (Phillips, John) Modified on 10/27/2020 (nms). |
| Oct 26, 2020 | 100 | Main Document (5) Docket Text: DECLARATION re [98] MOTION for Attorney Fees Pursuant to 35 U.S.C. § 285, by FlatWing Pharmaceuticals, LLC. (Attachments: # (1) Exhibits A-Q)(Phillips, John) Modified on 10/27/2020 (nms). |
| Oct 26, 2020 | 100 | Exhibit A - Q (580) |
| Sep 11, 2020 | 96 | Judgment (3) Docket Text: FINAL JUDGMENT is entered in favor of Defendants and against Anacor on Anacor's claims of infringement, and on Defendants' counterclaims of invalidity (see Judgment for further details) (CASE CLOSED). Signed by Judge Richard G. Andrews on 9/11/2020. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA(nms) |
| Sep 11, 2020 | 97 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,459,938 B2; 9,566,289 B2; 9,566,290 B2; 9,572,823 B2. (Attachments: # (1) Judgment)(nms) |
| Sep 11, 2020 | 97 | Judgment (3) |
| Sep 10, 2020 | 95 | Main Document (3) Docket Text: PROPOSED Final Judgment, by Anacor Pharmaceuticals, Inc.. (Attachments: # (1) Letter)(Dellinger, Megan) Modified on 9/11/2020 (nms). |
| Sep 10, 2020 | 95 | Letter to Judge Andrews (1) |
| Aug 31, 2020 | 94 | Notice (Other) (4) Docket Text: Joint NOTICE of Federal Circuit Decision by Anacor Pharmaceuticals, Inc. (Dellinger, Megan) |
| Jul 9, 2020 | 23 | Motion to Stay (2) |
| Apr 22, 2020 | 93 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Nanomi B.V. for Lupin Limited, Lupin Limited; Corporate Parent Lupin Inc. for Lupin Pharmaceuticals, Inc., Lupin Pharmaceuticals, Inc. filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Mowery, Katharine) |
| Sep 23, 2019 | 92 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove David A. Gerasimow as co-counsel. Reason for request: No longer with Husch Blackwell LLP. (Haney, Megan) |
| Sep 19, 2019 | 90 | Order (3) Docket Text: ORDER TO STAY: The actions are stayed pending Plaintiff's appeal of the PTAB Decisions to the Federal Circuit. The parties will notify the Court of the Federal Circuit's decision no later than three (3) days after it issues. The parties should be prepared to submit with the notification their requests for how to proceed. Signed by Judge Richard G. Andrews on 9/19/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:19-cv-00632-RGA(nms) |
| Sep 19, 2019 | 91 | Order Administratively Closing Case (2) Docket Text: ORDER: The cases are ADMINISTRATIVELY CLOSED. The parties shall promptly notify the Court when the "Federal Circuit" has resolved the appeal so that these case may be reopened and other appropriate action may be taken. Signed by Judge Richard G. Andrews on 9/19/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:19-cv-00632-RGA(nms) |
| Sep 13, 2019 | 88 | Letter (4) |
| Sep 13, 2019 | 88 | Exhibit 1-2 (7) |
| Sep 13, 2019 | 89 | Letter (9) |
| Sep 13, 2019 | 89 | Text of Proposed Order (4) |
| Sep 13, 2019 | 88 | Main Document (4) Docket Text: Letter to The Honorable Richard G. Andrews from Megan E. Dellinger regarding Proposed Stay. (Attachments: # (1) Exhibit 1-2)(Dellinger, Megan) |
| Sep 13, 2019 | 89 | Main Document (9) Docket Text: Letter to Honorable Richard G. Andrews from Kelly E. Farnan regarding Defendants' Support of Their Stay Proposal. (Attachments: # (1) Text of Proposed Order)(Farnan, Kelly) |
| Aug 27, 2019 | 87 | Order (5) Docket Text: ORDER re (71 in 19-cv-632-RGA, 129 in 18-cv-1673-RGA, 86 in 18-cv-1606-RGA, 62 in 19-md-2884-RGA) Stipulation and Order to File Competing Stay Proposals. Signed by Judge Richard G. Andrews on 8/27/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:19-cv-00632-RGA(nms) |
| Aug 26, 2019 | 86 | Stipulation (5) Docket Text: STIPULATION and [Proposed] Order to File Competing Stay Proposals by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc., Encube Ethicals Pvt. Ltd.. (Farnan, Kelly) |
| Aug 14, 2019 | 85 | Stipulation (5) Docket Text: STIPULATION and Order to Amend Scheduling Order by Anacor Pharmaceuticals, Inc., Anacor Pharmaceuticals, Inc.. (Dellinger, Megan) |
| Aug 8, 2019 | N/A | SO ORDERED (0) |
| Aug 7, 2019 | 84 | Stipulation (7) Docket Text: STIPULATION to Amend Scheduling Order by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc.. (Kraman, Pilar) |
| Jul 31, 2019 | N/A | SO ORDERED (0) |
| Jul 31, 2019 | 83 | Stipulation to EXTEND Time (7) Docket Text: STIPULATION TO EXTEND TIME re: Protective Order to and including August 14, 2019 - filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc., Encube Ethicals Pvt. Ltd.. (Farnan, Kelly) |
| Jul 25, 2019 | N/A | SO ORDERED (0) |
| Jul 24, 2019 | 82 | Stipulation (7) Docket Text: STIPULATION and Order to Amend Scheduling Order by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Mowery, Katharine) |
| Jul 17, 2019 | N/A | SO ORDERED (0) |
| Jul 16, 2019 | 81 | Stipulation to EXTEND Time (7) Docket Text: STIPULATION TO EXTEND TIME to file a protective order to July 31, 2019 - filed by Mylan Inc., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) Modified on 7/17/2019 (nms). |
| Jun 27, 2019 | 80 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Flatwing Pharmaceuticals, LLC's Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery and Defendant Flatwing Pharmaceuticals, LLC's Initial Disclosures Pursuant to Rule 26(a)(1) filed by FlatWing Pharmaceuticals, LLC.(Phillips, John) |
| Jun 26, 2019 | N/A | Order (0) |
| Jun 25, 2019 | 79 | Stipulation (8) Docket Text: STIPULATION and Order to Amend Scheduling Order by Mylan Inc., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) |
| Jun 13, 2019 | N/A | SO ORDERED (0) |
| Jun 13, 2019 | 78 | Stipulation to EXTEND Time (9) Docket Text: STIPULATION TO EXTEND TIME Proposed Protective Order to and including June 27, 2019 - filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc., Encube Ethicals Pvt. Ltd.. (Farnan, Kelly) |
| Jun 11, 2019 | N/A | SO ORDERED (0) |
| Jun 11, 2019 | 76 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME Paragraph 3 Default Standard Disclosures and Rule 26(a) Initial Disclosures to June 27, 2019 - filed by FlatWing Pharmaceuticals, LLC. (Haney, Megan) |
| Jun 11, 2019 | 77 | Order (2) Docket Text: SO ORDER Granting (75 in 18-cv-1606-RGA, 43 in 19-md-2884-RGA) Stipulation of Dismissal (*Glasshouse Pharmaceuticals Limited Canada terminated). Signed by Judge Richard G. Andrews on 6/11/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA(nms) |
| Jun 10, 2019 | 75 | Stipulation of Dismissal (2) Docket Text: STIPULATION and Order of Dismissal, by Glasshouse Pharmaceuticals Limited Canada. (Keller, Karen) Modified on 6/11/2019 (nms). |
| May 31, 2019 | N/A | SO ORDERED (0) |
| May 30, 2019 | N/A | SO ORDERED (0) |
| May 30, 2019 | N/A | SO ORDERED (0) |
| May 30, 2019 | 70 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order to Extend Time, by Glasshouse Pharmaceuticals Limited Canada. (Keller, Karen) Modified on 5/30/2019 (nms). |
| May 30, 2019 | 71 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Lupin Ltd. and Lupin Pharmaceuticals, Inc.s Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery and Lupin Ltd. and Lupin Pharmaceuticals, Inc.s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Mowery, Katharine) |
| May 30, 2019 | 72 | Stipulation to EXTEND Time (7) Docket Text: STIPULATION TO EXTEND TIME Deadline for the Parties to Submit a Proposed Protective Order to June 13, 2019 - filed by Perrigo Company plc, Perrigo Pharma International DAC. (Ovanesian, Michelle) |
| May 30, 2019 | 73 | Notice of Service (18) Docket Text: NOTICE OF SERVICE of (1) Anacor's Rule 26(a) Initial Disclosures and (2) Anacor's Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Anacor Pharmaceuticals, Inc..(Dellinger, Megan) |
| May 30, 2019 | 74 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Encube Ethicals Pvt. Ltd.'s: (1) Initial Disclosures Under Rule 26(a)(1) and (2) Initial Disclosures Under Paragraph 3 of the Default Standard for Discovery filed by Encube Ethicals Pvt. Ltd..(Farnan, Kelly) |
| May 29, 2019 | 69 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME extend deadlines for Paragraph 3 Default Standard Disclosures and Rule 26(a) Initial Disclosures to June 11, 2019 - filed by FlatWing Pharmaceuticals, LLC. (Haney, Megan) |
| May 17, 2019 | 68 | Answer to Counterclaim (17) Docket Text: ANSWER to [64] Answer to Complaint, and Counterclaims, by Anacor Pharmaceuticals, Inc..(Dellinger, Megan) Modified on 5/20/2019 (nms). |
| May 1, 2019 | 67 | Scheduling Order (11) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 12/20/2019. Amended Pleadings due by 12/20/2019. Fact Discovery completed by 7/31/2020. Status Report due by 7/31/2020. Joint Claim Construction Brief due by 3/12/2020. A Markman Hearing is set for 4/13/2020, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 3/26/2021, at 9:00 AM in Courtroom 6A. A 3-5 day Bench Trial is set to begin 4/12/2021, at 9:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 4/30/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:19-cv-00632-RGA(nms) |
| Apr 30, 2019 | 66 | Letter (1) |
| Apr 30, 2019 | 66 | Revised Proposed Scheduling Order (13) |
| Apr 30, 2019 | 66 | Main Document (1) Docket Text: Letter to The Honorable Richard G. Andrews from Megan E. Dellinger regarding Revised Proposed Scheduling Order. (Attachments: # (1) Revised Proposed Scheduling Order)(Dellinger, Megan) |
| Apr 26, 2019 | 64 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, and COUNTERCLAIMS against Anacor Pharmaceuticals, Inc. by Glasshouse Pharmaceuticals Limited Canada.(Fry, David) Modified on 4/29/2019 (nms). |
| Apr 26, 2019 | 65 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Contract Pharmaceuticals Limited for Glasshouse Pharmaceuticals Limited Canada filed by Glasshouse Pharmaceuticals Limited Canada. (Fry, David) |
| Apr 25, 2019 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Scheduling Conference held on 4/25/2019. Local counsel present for plaintiff: M. Dellinger. Local counsel present for defendants: P. Kraman, A. Gaza, K. Farnan, D. Moore, K. Mowery, N. Hoeschen, R. Touhey Myer, M. Haney, K. Harmon, K. Dorsney, S. Coyle. (Court Reporter Heather Triozzi.) Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:19-cv-00632-RGA(crb) |
| Apr 23, 2019 | 63 | Letter (1) |
| Apr 23, 2019 | 63 | Proposed Order (13) |
| Apr 23, 2019 | 63 | Main Document (1) Docket Text: Letter to The Honorable Richard G. Andrews from Megan E. Dellinger regarding Proposed Scheduling Order. (Attachments: # (1) Proposed Order)(Dellinger, Megan) Modified on 4/24/2019 (nms). |
| Apr 15, 2019 | N/A | SO ORDERED (0) |
| Apr 12, 2019 | 62 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to move, plead or otherwise respond to the Complaint to April 26, 2019 - filed by Glasshouse Pharmaceuticals Limited Canada. (Fry, David) |
| Apr 9, 2019 | 61 | ANDA Form (2) Docket Text: Amended Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: See Attached. Date of Expiration of Patent: August 16, 2026. (Dellinger, Megan) |
| Apr 5, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER: A Scheduling Conference is now set for 4/25/2019, at 3:00 PM in Courtroom 6A before Judge Richard G. Andrews. The parties shall confer about scheduling and discovery limitations, and attempt to reach agreement. The parties shall use as a basis for discussion the Courts Rule 16 Scheduling Order patent, available on the Courts website. No later than 48 hours before the scheduling conference, the parties shall file a proposed scheduling order using the Rule 16 Scheduling Order - patent form. Ordered by Judge Richard G. Andrews on 4/5/2019. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:19-cv-00632-RGA(nms) |
| Apr 3, 2019 | N/A | Remark - MDL Member (0) Docket Text: NOTICE: Documents relating to all actions should be filed on the master docket sheet and on the docket sheet of each individual action. Documents relating to two or more, but not all, individual actions should be filed on the master docket sheet, and on the docket sheet of each affected individual action. Documents affecting a single individual action should be filed on the docket sheet of that action and on the master docket sheet. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA(rwc) |
| Apr 3, 2019 | 58 | Order (4) Docket Text: CERTIFIED TRANSFER ORDER - issued by the Panel on Multi-District Litigation on 4/3/19. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA(rwc) |
| Apr 3, 2019 | 59 | Remark - MDL Notice to Counsel (1) Docket Text: NOTICE TO COUNSEL: MDL No. 1:19-md-2884 has been opened and assigned to the Honorable Richard G. Andrews. Attorneys of record who will be electronically filing documents may use the attached form to register for a CM/ECF login and password. Please see the docket for further entries. Associated Cases: 1:19-md-02884-RGA, 1:18-cv-01606-RGA, 1:18-cv-01673-RGA(rwc) |
| Apr 1, 2019 | N/A | SO ORDERED (0) |
| Mar 29, 2019 | 57 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME (and proposed order) to move, plead or otherwise respond to the complaint to April 12, 2019 - filed by Glasshouse Pharmaceuticals Limited Canada. (Fry, David) |
| Mar 15, 2019 | N/A | SO ORDERED (0) |
| Mar 15, 2019 | 56 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to Respond to the Complaint to March 29, 2019 - filed by Glasshouse Pharmaceuticals Limited Canada. (Keller, Karen) |
| Mar 1, 2019 | N/A | SO ORDERED (0) |
| Mar 1, 2019 | N/A | Oral Order (0) |
| Feb 28, 2019 | 54 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION and Proposed Order to Extend Time - filed by Glasshouse Pharmaceuticals Limited Canada. (Keller, Karen) Modified on 3/1/2019 (nms). |
| Feb 15, 2019 | N/A | SO ORDERED (0) |
| Feb 14, 2019 | 53 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION and Proposed Order to move, plead or otherwise respond to the Complaint to March 1, 2019 - filed by Glasshouse Pharmaceuticals Limited Canada. (Keller, Karen) Modified on 2/15/2019 (nms). |
| Feb 8, 2019 | 51 | Request for Oral Argument (8) Docket Text: REQUEST for Oral Argument by Amneal Pharmaceuticals LLC re [34] in MOTION. (Gaza, Anne) Modified on 2/11/2019 (nms). |
| Feb 8, 2019 | 52 | Request for Oral Argument (1) Docket Text: REQUEST for Oral Argument by FlatWing Pharmaceuticals, LLC re [34] MOTION for. (Phillips, John) |
| Feb 1, 2019 | N/A | SO ORDERED (0) |
| Feb 1, 2019 | 49 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME (and proposed order) to move, plead or otherwise respond to the Complaint to February 15, 2019 - filed by Glasshouse Pharmaceuticals Limited Canada. (Keller, Karen) |
| Feb 1, 2019 | 50 | Reply Brief (18) Docket Text: REPLY BRIEF re [34] Cross-Motion to Stay Cases, filed by Anacor Pharmaceuticals, Inc.. (Dellinger, Megan) Modified on 2/4/2019 (nms). |
| Jan 24, 2019 | 48 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Frederick L. Cottrell, III on behalf of Lupin Limited, Lupin Pharmaceuticals, Inc. (Cottrell, Frederick) |
| Jan 23, 2019 | N/A | SO ORDERED (0) |
| Jan 23, 2019 | 47 | Request for Oral Argument (1) Docket Text: REQUEST for Oral Argument by FlatWing Pharmaceuticals, LLC re [23] MOTION to Stay Case Pending Resolution of Inter Partes Review. (Phillips, John) |
| Jan 22, 2019 | 46 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to move, plead or otherwise respond to the Complaint to February 1, 2019 - filed by Glasshouse Pharmaceuticals Limited Canada. (Keller, Karen) |
| Jan 16, 2019 | N/A | SO ORDERED (0) |
| Jan 16, 2019 | 45 | Declaration (3) |
| Jan 16, 2019 | 44 | Brief (Combined Answering and Reply) (15) Docket Text: Combined Answering and Reply Brief re [34] MOTION to Stay, and [23] MOTION to Stay Case Pending Resolution of Inter Partes Review, filed by FlatWing Pharmaceuticals, LLC.Reply Brief due date per Local Rules is 1/23/2019. (Phillips, John) Modified on 1/17/2019 (nms). |
| Jan 16, 2019 | 45 | Exhibit M (8) |
| Jan 16, 2019 | 45 | Exhibit N (45) |
| Jan 16, 2019 | 45 | Exhibit O (6) |
| Jan 16, 2019 | 45 | Exhibit P (9) |
| Jan 16, 2019 | 45 | Main Document (3) Docket Text: DECLARATION of David A. Gerasimow re [41] Answering Brief in Opposition, by FlatWing Pharmaceuticals, LLC. (Attachments: # (1) Exhibit M, # (2) Exhibit N, # (3) Exhibit O, # (4) Exhibit P)(Phillips, John) Modified on 1/17/2019 (nms). |
| Jan 15, 2019 | 43 | Stipulation to EXTEND Time (5) Docket Text: STIPULATION and Proposed Order to Extend Time - filed by Anacor Pharmaceuticals, Inc.. (Dellinger, Megan) Modified on 1/16/2019 (nms). |
| Jan 14, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Megan E. Hingtgen for Encube Ethicals Pvt. Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Jan 11, 2019 | N/A | SO ORDERED (0) |
| Jan 11, 2019 | 42 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Megan E. Hingtgen - filed by Encube Ethicals Pvt. Ltd.. (Farnan, Kelly) |
| Jan 9, 2019 | N/A | SO ORDERED (0) |
| Jan 9, 2019 | 41 | Answering Brief in Opposition (25) |
| Jan 9, 2019 | 41 | Exhibit 1 (48) |
| Jan 9, 2019 | 41 | Main Document (25) Docket Text: ANSWERING BRIEF in Opposition re [23] MOTION to Stay Case Pending Resolution of Inter Partes Review, and [34] Cross-Motion, filed by Lupin Limited, Lupin Pharmaceuticals, Inc..Reply Brief due date per Local Rules is 1/16/2019. (Attachments: # (1) Exhibit 1)(Mowery, Katharine) Modified on 1/10/2019 (nms). |
| Jan 8, 2019 | 40 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to Respond to the Complaint to January 23, 2019 - filed by Glasshouse Pharmaceuticals Limited Canada. (Keller, Karen) |
| Jan 3, 2019 | N/A | SO ORDERED (0) |
| Jan 3, 2019 | N/A | Add Attorneys Pro Hac Vice (0) |
| Jan 2, 2019 | N/A | SO ORDERED (0) |
| Jan 2, 2019 | 39 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Aryeh N. Feinstein - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Mowery, Katharine) |
| Dec 21, 2018 | N/A | SO ORDERED (0) |
| Dec 21, 2018 | N/A | SO ORDERED (0) |
| Dec 21, 2018 | 38 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Respond to Anacor Pharmaceuticals, Inc.'s Cross-Motion to Stay to January 16, 2019 - filed by FlatWing Pharmaceuticals, LLC. (Phillips, John) |
| Dec 20, 2018 | 36 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Respond to Plaintiff Anacor's Cross-Motion to Stay to January 9, 2019 - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Mowery, Katharine) |
| Dec 20, 2018 | 37 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Respond to Flawting Pharmaceuticals, LLC's Motion to Stay to January 9, 2019 - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Mowery, Katharine) |
| Dec 19, 2018 | N/A | SO ORDERED (0) |
| Dec 18, 2018 | 35 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME Defendant Encube Ethical's Response to Cross Motion to Stay All Cases Against All Defendants DI.23 to and including January 9, 2019 - filed by Encube Ethicals Pvt. Ltd.. (Farnan, Kelly) |
| Dec 11, 2018 | N/A | CORRECTING ENTRY: (0) |
| Dec 10, 2018 | N/A | SO ORDERED (0) |
| Dec 10, 2018 | N/A | SO ORDERED (0) |
| Dec 10, 2018 | N/A | Set Answering Brief Deadline (0) Docket Text: Set Answering Brief Deadline re [34] Cross-Motion to Stay All Cases Against All Defendants. Answering Brief/Response due date per Local Rules is 12/24/2018. (nms) |
| Dec 10, 2018 | 33 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, and Defenses, by FlatWing Pharmaceuticals, LLC.(Phillips, John) Modified on 12/11/2018 (nms). |
| Dec 10, 2018 | 34 | Motion for Bond (12) Docket Text: RESPONSE to [23] MOTION to Stay Case Pending Resolution of Inter Partes Review and Cross-Motion to Stay All Cases Against All Defendants, filed by Anacor Pharmaceuticals, Inc.. (Dellinger, Megan) Modified on 12/11/2018 (nms). Modified on 12/11/2018 (nms). |
| Dec 7, 2018 | 31 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to Respond to Complaint to January 9, 2019 - filed by Glasshouse Pharmaceuticals Limited Canada. (Keller, Karen) |
| Dec 7, 2018 | 32 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to Respond to FlatWing's Motion to Stay and Opening Brief to December 26, 2018 - filed by Encube Ethicals Pvt. Ltd.. (Farnan, Kelly) |
| Dec 6, 2018 | 30 | Answer to Counterclaim (11) Docket Text: ANSWER to [19] Answer to Complaint, and Counterclaims, by Anacor Pharmaceuticals, Inc..(Blumenfeld, Jack) Modified on 12/7/2018 (nms). |
| Nov 29, 2018 | 29 | Answer to Counterclaim (8) Docket Text: ANSWER to [16] Answer to Complaint, and Counterclaims, by Anacor Pharmaceuticals, Inc..(Blumenfeld, Jack) Modified on 11/30/2018 (nms). |
| Nov 28, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Nov 27, 2018 | N/A | SO ORDERED (0) |
| Nov 27, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Nov 27, 2018 | N/A | SO ORDERED (0) |
| Nov 27, 2018 | 27 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Wicker Pharmaceuticals, LLC for FlatWing Pharmaceuticals, LLC filed by FlatWing Pharmaceuticals, LLC. (Phillips, John) |
| Nov 27, 2018 | 28 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Don J. Mizerk - filed by FlatWing Pharmaceuticals, LLC. (Haney, Megan) |
| Nov 26, 2018 | 25 | Declaration (3) |
| Nov 26, 2018 | 23 | Text of Proposed Order (1) |
| Nov 26, 2018 | 24 | Opening Brief in Support (15) Docket Text: OPENING BRIEF in Support re [23] MOTION to Stay Case Pending Resolution of Inter Partes Review, filed by FlatWing Pharmaceuticals, LLC.Answering Brief/Response due date per Local Rules is 12/10/2018. (Phillips, John) Modified on 11/27/2018 (nms). |
| Nov 26, 2018 | 25 | Exhibit A (84) |
| Nov 26, 2018 | 25 | Exhibit B (80) |
| Nov 26, 2018 | 25 | Exhibit C (84) |
| Nov 26, 2018 | 25 | Exhibit D (84) |
| Nov 26, 2018 | 25 | Exhibit E (17) |
| Nov 26, 2018 | 25 | Exhibit F (18) |
| Nov 26, 2018 | 25 | Exhibit G (18) |
| Nov 26, 2018 | 25 | Exhibit H (18) |
| Nov 26, 2018 | 25 | Exhibit I (10) |
| Nov 26, 2018 | 25 | Exhibit J (10) |
| Nov 26, 2018 | 25 | Exhibit K (63) |
| Nov 26, 2018 | 25 | Exhibit L (61) |
| Nov 26, 2018 | 26 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Marc R. Wezowski and David Gerasimow - filed by FlatWing Pharmaceuticals, LLC. (Haney, Megan) |
| Nov 26, 2018 | 23 | Main Document (2) Docket Text: MOTION to Stay Case Pending Resolution of Inter Partes Review - filed by FlatWing Pharmaceuticals, LLC. (Attachments: # (1) Proposed Order)(Phillips, John) Modified on 11/27/2018 (nms). |
| Nov 26, 2018 | 25 | Main Document (3) Docket Text: DECLARATION of David A. Gerasimow re [23] MOTION to Stay Case Pending Resolution of Inter Partes Review, by FlatWing Pharmaceuticals, LLC. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L)(Phillips, John) Modified on 11/27/2018 (nms). |
| Nov 20, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Nov 16, 2018 | N/A | SO ORDERED (0) |
| Nov 16, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:18-cv-01606-RGA, 1:18-cv-01673-RGA, 1:18-cv-01699-RGA (rjb) |
| Nov 16, 2018 | 22 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Renee Marie Mosley on behalf of Encube Ethicals Pvt. Ltd. (Mosley, Renee) |
| Nov 15, 2018 | 19 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, Defenses and, COUNTERCLAIM against Anacor Pharmaceuticals, Inc. by Encube Ethicals Pvt. Ltd..(Farnan, Kelly) |
| Nov 15, 2018 | 20 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Encube Ethicals Pvt. Ltd.. (Farnan, Kelly) |
| Nov 15, 2018 | 21 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Gary J. Speier and Samuel T. Lockner - filed by Encube Ethicals Pvt. Ltd.. (Farnan, Kelly) |
| Nov 14, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Nov 14, 2018 | N/A | SO ORDERED (0) |
| Nov 9, 2018 | N/A | SO ORDERED (0) |
| Nov 8, 2018 | 16 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, and COUNTERCLAIM of Lupin Ltd. against Anacor Pharmaceuticals, Inc., by Lupin Limited, Lupin Pharmaceuticals, Inc..(Mowery, Katharine) Modified on 11/19/2018 (nms). |
| Nov 8, 2018 | 17 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Lupin Atlantis Holdings S.A. for Lupin Limited; Corporate Parent Lupin Ltd., Corporate Parent Lupin Inc. for Lupin Pharmaceuticals, Inc. filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Mowery, Katharine) |
| Nov 8, 2018 | 18 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney William R. Zimmerman, Carol Pitzel Cruz and Andrea L. Cheek - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Mowery, Katharine) |
| Nov 6, 2018 | 14 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Respond to the Complaint to December 10, 2018 - filed by Glasshouse Pharmaceuticals Limited Canada. (Keller, Karen) |
| Nov 6, 2018 | 15 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for defendant Encube Ethicals Pvt. Ltd. to respond to the Complaint to December 10, 2018 - filed by Anacor Pharmaceuticals, Inc.. (Dellinger, Megan) |
| Nov 5, 2018 | 13 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Flatwing to answer, plead or otherwise respond to the Complaint (D.I. 1) to December 10, 2018 - filed by FlatWing Pharmaceuticals, LLC. (Phillips, John) |
| Nov 1, 2018 | N/A | SO ORDERED (0) |
| Oct 31, 2018 | 10 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Aaron P. Maurer, David I. Berl, David M. Horniak and Anthony Sheh of Williams & Connolly LLP - filed by Anacor Pharmaceuticals, Inc.. (Dellinger, Megan) |
| Oct 31, 2018 | 11 | Request for Waiver of Service (1) Docket Text: REQUEST FOR WAIVER of Service sent to Lupin Limited on 10/29/2018 by Anacor Pharmaceuticals, Inc.. (Blumenfeld, Jack) |
| Oct 31, 2018 | 12 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Anacor Pharmaceuticals, Inc.: For Lupin Limited waiver sent on 10/29/2018, answer due 12/28/2018. (Blumenfeld, Jack) |
| Oct 24, 2018 | N/A | Case Assigned/Reassigned (0) |
| Oct 23, 2018 | 9 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Anacor Pharmaceuticals, Inc.. Encube Ethicals Pvt. Ltd. served on 10/18/2018, answer due 11/8/2018. (Blumenfeld, Jack) |
| Oct 19, 2018 | 7 | Return of Service Executed (2) Docket Text: Return of Service Executed by Anacor Pharmaceuticals, Inc.. FlatWing Pharmaceuticals, LLC served on 10/18/2018, answer due 11/8/2018. (Blumenfeld, Jack) |
| Oct 19, 2018 | 8 | Return of Service Executed (2) Docket Text: Return of Service Executed by Anacor Pharmaceuticals, Inc.. Glasshouse Pharmaceuticals Limited Canada served on 10/18/2018, answer due 11/8/2018. (Blumenfeld, Jack) |
| Oct 18, 2018 | 6 | Return of Service Executed (2) Docket Text: Return of Service Executed by Anacor Pharmaceuticals, Inc.. Lupin Pharmaceuticals, Inc. served on 10/18/2018, answer due 11/8/2018. (Blumenfeld, Jack) |
| Oct 17, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Encube Ethicals Pvt. Ltd. on 10/17/2018; FlatWing Pharmaceuticals, LLC on 10/17/2018; Glasshouse Pharmaceuticals Limited Canada on 10/17/2018; Lupin Limited on 10/17/2018; Lupin Pharmaceuticals, Inc. on 10/17/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) |
| Oct 17, 2018 | 1 | Complaint (34) |
| Oct 17, 2018 | 1 | Exhibit A-D (961) |
| Oct 17, 2018 | 1 | Civil Cover Sheet (1) |
| Oct 17, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Oct 17, 2018 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: See Attached. Date of Expiration of Patent: 2/16/2026. Thirty Month Stay Deadline: See Attached. (nmg) |
| Oct 17, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,459,938 B2; 9,566,289 B2; 9,566,290 B2; 9,572,823 B2. (nmg) |
| Oct 17, 2018 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for Anacor Pharmaceuticals, Inc. filed by Anacor Pharmaceuticals, Inc.. (nmg) |
| Oct 17, 2018 | 1 | Main Document (34) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against Encube Ethicals Pvt. Ltd., FlatWing Pharmaceuticals, LLC, Glasshouse Pharmaceuticals Limited Canada, Lupin Limited, Lupin Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2483254.) - filed by Anacor Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit A-D, # (2) Civil Cover Sheet)(nmg) |
| Oct 17, 2018 | 1 | Complaint* (1) |
